United to change the trajectory of lung cancer
At Johnson & Johnson, we collaborate across our Pharmaceutical and MedTech teams and with strategic partners to unleash the full potential of lung cancer science to help change the trajectory of this complex disease.
Lung cancer requires a multidisciplinary approach
